---

Medical Devices: Technology

Answer

The recently announced £650 million life sciences package will support the delivery of plans for accelerating the development, adoption and spread of innovation to bring new products to patients faster, in line with the Life Sciences Vision (LSV). Through the LSV, we are also advancing plans for a new regulatory pathway, which will facilitate the development and uptake of beneficial innovative technologies, and are progressing work to improve the capability to generate Real World Evidence, which will support the National Health Service in selecting products that provide positive patient outcomes.

The Government's new Medical Technology Strategy, published in February 2023, builds on the LSV to set out how the health and social care system can reliably access safe, effective and innovative medical technologies that support the continued delivery of high-quality care, outstanding patient safety and excellent patient outcomes in a way that makes the best use of taxpayer money.

Through the Medical Technology Strategy, we are working closely with NHS Supply Chain and NHS England to implement a consistent methodology for value-based procurement to be adopted at a national and local level and ultimately to provide positive patient outcomes.

Secondary information

Type

Written question

Reference

194150

Session

2022-23

Subjects

Procurement Safety Technology Medical devices Life sciences

Link

View this Written question on www.parliament.uk